AP-301 (Alebund Pharmaceuticals)

N/A

Report date: 2025/06/26 20:00:07
NME

Base Information

Drug NameAP-301 (Alebund Pharmaceuticals)
Drug Alias NameNovel phosphate binder derived from Fe (III) and gum Arabic in a complex (Vidasym)金合欢树树液提取物 （礼邦医药）VS-505
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphates binders
TargetsPhosphates
Therapy Area/IndicationsHyperphosphatemiaKidney Failure, ChronicRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesVidasym IncShanghai Alebund Pharmaceuticals LtdK.D.L. Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesOrient Pharma Co LtdAlebund Pharmaceuticals (Hong Kong) LtdLibang Biological Medicine (Jiangsu) Co Ltd +[4] 
Inactive CompaniesK.D.L. Inc
Active IndicationsHyperphosphatemiaKidney Failure, ChronicRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A